MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517067354 A) filed by Empirico Inc., San Diego, on July 15, for 'treatment of mst1 related diseases and disorders.'
Inventor(s) include Gottesman, Omri; Bruse, Shannon; Buske, Paul; Cajes, Brian; Jakubosky, David; Kleinstein, Sarah; Lewis, David; Rozema, David; and Vekich, John.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Disclosed herein are compositions comprising an oligonucleotide that targets MST1. The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods of treating conditions associated with MST1 variants that include providing an oligonucleotide that targets MST1 to a subject."
The patent application was internationally filed on Dec. 13, 2023, under International application No.PCT/US2023/083875.
Disclaimer: Curated by HT Syndication.
